This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: J Wesley Pike: Innovator in Retinoid Receptor Research
Introduction
J Wesley Pike is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of biochemistry, particularly in the study of retinoid receptors. His work has implications for understanding various biological processes and potential therapeutic applications.
Latest Patents
J Wesley Pike holds a patent for the "Detection of retinoid X receptor subtype .gamma. proteins." This invention features peptides derived from RXRX and antibodies elicited by these peptides. The antibodies bind specifically to RXRX subtypes in their native, functional conformation. The patent also discloses methods for detecting RXRX using these antibodies in immunological assays. Additionally, it describes a hormone-binding immunoprecipitation assay that utilizes both retinoid receptor subtype-specific antibodies and retinoid receptor ligands to detect and measure RXR and RAR subtypes in a sample. A method for determining the profile of retinoid receptor subfamily members with retinoid receptor ligands is also included.
Career Highlights
J Wesley Pike is associated with Ligand Pharmaceuticals, Inc., where he continues to advance research in his field. His innovative work has garnered attention and recognition within the scientific community.
Collaborations
One of his notable coworkers is Elizabeth A Allegretto, with whom he has likely collaborated on various projects related to retinoid receptors and their functions.
Conclusion
J Wesley Pike's contributions to the field of retinoid receptor research highlight his innovative spirit and dedication to advancing scientific knowledge. His patent and ongoing work at Ligand Pharmaceuticals, Inc. reflect his commitment to improving our understanding of complex biological systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
